open access
Vitamin D3 promotes oligodendrogenesis and modulates synucleinopathy in lead-induced nigral pars compacta neurotoxicity in rats
, 2
Affiliations- Department of Anatomy and Embryology, Faculty of Medicine, Cairo University, Egypt
- Department of Anatomy and Embryology, Faculty of Medicine, Ain Shams University, Egypt
open access
Abstract
Background: Lead-induced neurotoxicity was marked with locomotor and Parkinsonian-like changes. Oligodendrocytes and synucleinopathy were signed to in the pathophysiology of some neurodegenerative diseases. Vitamin D3’s (D3) role in substantia nigra pars compacta (SNpc) disorders is debated between neuroscientists. The aim of the study was to investigate lead-induced SNpc neurotoxic changes and explore the possible neuroprotective role of D3 and the possible involvement of oligodendrocytes and α-synuclein.
Materials and methods: This study included 40 adult Wistar rats assigned into four equal groups: control, lead (Pb) (in drinking water, 1,000 mg/L), Pb + D3 (D3 injection, 1,000 IU/kg IM; 3 days/week), and D3. After 8 weeks, the rats were sacrificed, and their midbrain underwent biochemical and immunoblotting analysis. Midbrain paraffin blocks were stained for histological and immunohistochemical assessment.
Results: Lead (Pb) had increased significantly (p < 0.05) nigral α-synuclein and caspase-11 by immunoblotting analysis. Histologically, it induced neurodegeneration in SNpc and significantly decreased neuronal cell density by cresyl violet staining. Pb also significantly reduced SNpc tyrosine hydroxylase immunoreaction, significantly elevated glial fibrillatory acid protein (GFAP) and α-synuclein immunoreaction associated with a mild but significant increase in caspase-3. In the Pb + D3 group, all the previous deleterious changes were significantly alleviated in addition to significant upregulation of anti-oligodendrocytes immunoexpression.
Conclusions: Lead (Pb) may induce SNpc neurotoxicity presumably via activation of caspase-11 and α-synuclein. D3 may modulate this neurotoxicity probably through an oligodendrogenic effect.
Abstract
Background: Lead-induced neurotoxicity was marked with locomotor and Parkinsonian-like changes. Oligodendrocytes and synucleinopathy were signed to in the pathophysiology of some neurodegenerative diseases. Vitamin D3’s (D3) role in substantia nigra pars compacta (SNpc) disorders is debated between neuroscientists. The aim of the study was to investigate lead-induced SNpc neurotoxic changes and explore the possible neuroprotective role of D3 and the possible involvement of oligodendrocytes and α-synuclein.
Materials and methods: This study included 40 adult Wistar rats assigned into four equal groups: control, lead (Pb) (in drinking water, 1,000 mg/L), Pb + D3 (D3 injection, 1,000 IU/kg IM; 3 days/week), and D3. After 8 weeks, the rats were sacrificed, and their midbrain underwent biochemical and immunoblotting analysis. Midbrain paraffin blocks were stained for histological and immunohistochemical assessment.
Results: Lead (Pb) had increased significantly (p < 0.05) nigral α-synuclein and caspase-11 by immunoblotting analysis. Histologically, it induced neurodegeneration in SNpc and significantly decreased neuronal cell density by cresyl violet staining. Pb also significantly reduced SNpc tyrosine hydroxylase immunoreaction, significantly elevated glial fibrillatory acid protein (GFAP) and α-synuclein immunoreaction associated with a mild but significant increase in caspase-3. In the Pb + D3 group, all the previous deleterious changes were significantly alleviated in addition to significant upregulation of anti-oligodendrocytes immunoexpression.
Conclusions: Lead (Pb) may induce SNpc neurotoxicity presumably via activation of caspase-11 and α-synuclein. D3 may modulate this neurotoxicity probably through an oligodendrogenic effect.
Keywords
lead (Pb), pars compacta, D3-synucleiopathy, oligodendrocytes
About this articleTitle
Vitamin D3 promotes oligodendrogenesis and modulates synucleinopathy in lead-induced nigral pars compacta neurotoxicity in rats
Journal
Issue
Article type
Original article
Pages
42-52
Published online
2022-01-17
Page views
3428
Article views/downloads
952
DOI
Pubmed
Bibliographic record
Folia Morphol 2023;82(1):42-52.
Keywords
lead (Pb)
pars compacta
D3-synucleiopathy
oligodendrocytes
Authors
R. A. Imam
M. R. Abdel-Hamed
References (21)- Abubakar K, Muhammad Mailafiya M, Danmaigoro A, et al. Curcumin attenuates lead-induced cerebellar toxicity in rats via chelating activity and inhibition of oxidative stress. Biomolecules. 2019; 9(9).
- Anderson FL, von Herrmann KM, Andrew AS, et al. Plasma-borne indicators of inflammasome activity in Parkinson's disease patients. NPJ Parkinsons Dis. 2021; 7(1): 2.
- Bancroft JD, Layton C. Connective and other mesenchymal tissues with their stains. In: Suvarna SK, Bancroft JD (eds.). Bancroft’s Theory and Practice of Histological Techniques. Eighth Ed. Elsevier Limited 2019: 53–175.
- BaSalamah MA, Abdelghany AH, El-Boshy M, et al. Vitamin D alleviates lead induced renal and testicular injuries by immunomodulatory and antioxidant mechanisms in rats. Sci Rep. 2018; 8(1): 4853.
- Ellwanger JH, Franke SIR, Bordin DL, et al. Biological functions of selenium and its potential influence on Parkinson's disease. An Acad Bras Cienc. 2016; 88(3 Suppl): 1655–1674.
- Fullard ME, Duda JE. A review of the relationship between vitamin d and parkinson disease symptoms. Front Neurol. 2020; 11: 454.
- Furuya T, Hayakawa H, Yamada M, et al. Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. J Neurosci. 2004; 24(8): 1865–1872.
- Lima LAR, Lopes MJ, Costa RO, et al. Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats. J Neuroinflammation. 2018; 15(1): 249.
- Mahul-Mellier AL, Burtscher J, Maharjan N, et al. The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration. Proc Natl Acad Sci U S A. 2020; 117(9): 4971–4982.
- Marmion DJ, Rutkowski AA, Chatterjee D, et al. Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease. Neurobiol Dis. 2021; 148: 105184.
- Mason C, Xiao L, Imayama I, et al. Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial. Am J Clin Nutr. 2014; 99(5): 1015–1025.
- Nejm MB, Guimarães-Marques MJ, Oliveira LF, et al. Assessment of vitamin D and inflammatory markers profile in cardiac tissue on Parkinson disease animal model. Pharmacol Rep. 2020; 72(2): 296–304.
- Perry A, Brat DJ. Practical surgical neuropathology: a diagnostic approach. 2nd ed. Chapter 27: Biopsy Pathology of neurodegenerative disorders in adults. , Philadelphia, PA 2018.
- Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat Rev Dis Primers. 2017; 3: 17013.
- Pu H, Jiang X, Wei Z, et al. Repetitive and prolonged omega-3 fatty acid treatment after traumatic brain injury enhances long-term tissue restoration and cognitive recovery. Cell Transplant. 2017; 26(4): 555–569.
- Reyes JF, Rey NL, Bousset L, et al. Alpha-synuclein transfers from neurons to oligodendrocytes. Glia. 2014; 62(3): 387–398.
- Ross MH, Pawlina W. Histology: a text and atlas — with correlated cell and molecular biology. 7th ed. Chapter 12. Wolters Kluwer Health, Philadelphia 2016: 378.
- Sabbar M, Delaville C, De Deurwaerdère P, et al. Lead-Induced atypical parkinsonism in rats: behavioral, electrophysiological, and neurochemical evidence for a role of noradrenaline depletion. Front Neurosci. 2018; 12: 173.
- Wang T, Zheng W, Xu He, et al. Clioquinol inhibits zinc-triggered caspase activation in the hippocampal CA1 region of a global ischemic gerbil model. PLoS One. 2010; 5(7): e11888.
- Xu J, Yan HC, Yang Bo, et al. Effects of lead exposure on hippocampal metabotropic glutamate receptor subtype 3 and 7 in developmental rats. J Negat Results Biomed. 2009; 8: 5.
- Yachnis AT, Rivera-Zengotita ML. Neuropathology. Chapter: Arkinson's Disease and Related Alpha-Synucleinopathies. Saunders, an imprint of Elsevier Inc., Philadelphia 2014 : 258–264.
